[Interview] Using Generative AI to Rapidly Identify Novel Therapies for COVID-19
![[Interview] Using Generative AI to Rapidly Identify Novel Therapies for COVID-19](/files/blog/20200427_195844.6615_Variational_AI_cover.jpg)
Generative models have become one of the hottest areas in de-novo molecular design over just several years, basically revolutionizing our perception of what can be done with artificial intelligence in this area. One important aspect of generative models is that they can produce new quality hit molecules using combined data from various experimental and theoretical sources -- and output results rapidly.
One notable drug discovery startup betting on deep learning and generative models for innovative drug design is Vancouver-based Variational AI.